Hanmi Science Co Ltd (Hanmi Science) is a pharmaceutical company. Its research, development and commercialization of various active pharmaceutical ingredients, key intermediates, Cephalosporin APIs and cephalosporin finished dosage forms in both prescription and over-the-counter markets. Its pipeline includes efocipegtrutide, hm15912, lapsglucagon and bh3120, among others. Hanmi Science prescription includes prescription drugs including antidepressants, NSAIDs, neuropathic pain, oral care, hair growth, anti-inflammatory, osteoporosis and diabetes, among others.The company supplies its products across the world. Hanmi Science is headquartered in Hwaseong, Gyeonggi, South Korea.
Headquarters
South Korea
Address
Paltan Industrial Complex, 214, Muha-Ro, Paltan-Myeon, Hwaseong, 18536
Website
www.hanmiscience.co.kr
Telephone
82 2 4109114
No of Employees
98
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
008930 (KRX)
Revenue (2022)
$955.9M
19.3%
(2022 vs 2021)
EPS
XYZ
Net Income (2022)
XYZ
66.3%
(2022 vs 2021)
Market Cap*
$1.8B
Net Profit Margin (2022)
XYZ
39.4%
(2022 vs 2021)
* As of and is in US$
Hanmi Science Co Ltd premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Active Pharmaceutical Ingredients | Lapscoverytm |
| Key Intermediates | Pentambodytm |
| Cephalosporin API's | |
| XYZ | |
| XYZ | |
| XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2024 | Plans/Strategy | In April, the company announced its plans to be acquired by KKR. |
| 2023 | New Products/Services | In July, Hanmi Pharmaceutical launched an additional low-dose version of Clozartan Tablet, a new combination drug for hypertension. |
| 2023 | New Products/Services | In May, Hanmi Pharmaceutical launched a new sunscreen. |
Competitor Comparison
| Key Parameters | Hanmi Science Co Ltd | Easy Holdings Co Ltd | Chong Kun Dang Pharmaceutical Corp. | Daewoong Pharmaceutical Co Ltd | JW Holdings Corp |
|---|---|---|---|---|---|
| Headquarters | South Korea | South Korea | South Korea | South Korea | South Korea |
| City | Hwaseong | Seoul | Seoul | Hwaseong | Gwacheon |
| State/Province | - | - | - | - | Seoul |
| No. of Employees | 98 | 182 | 1,904 | 1,256 | 161 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Youngsook Song | Chief Executive Officer; Chairman | Executive Board | 2020 | 75 |
| Jongsu Woo | Director | Non Executive Board | 2020 | 56 |
| Taeseon Kwak | Director | Non Executive Board | 2022 | 65 |
| Yoochul Shin | Director | Non Executive Board | 2022 | 58 |
| Yongdeok Kim | Director | Non Executive Board | 2022 | 66 |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward